 Home > Active Ingredient News > Digestive System Information > AP&T: Skipping breakfast is associated with increased cardiovascular mortality in metabolic dysfunction-related fatty liver (MAFLD)

AP&T: Skipping breakfast is associated with increased cardiovascular mortality in metabolic dysfunction-related fatty liver (MAFLD)

 Last Update: 2022-01-07
 Source: Internet
 Author: User

Tags

american health connection

tofu health risks

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Heart vascular diseases (CVDs) is one of the main causes of death, in 2019, 1860 million people worldwide have lost their lives, has brought an increasing health and economic burden

FDA

A total of 9,926 people (including 3,004 MAFLD participants) who were 20 years of age or older in this study participated in the third National Health and Nutrition Examination Survey, and the researchers followed these patients for 27 years

During the 212,239 person-years of follow-up, the researchers recorded a total of 2,595 deaths, of which 603 were due to CVD

This study confirms that skipping breakfast is associated with a high risk of cardiovascular mortality in MAFLD, but does not have such an effect in individuals without MAFLD

Jiarong Xie.

Skipping breakfast is associated with an increased long-term cardiovascular mortality in metabolic dysfunction-associated fatty liver disease (MAFLD) but not MAFLD-free individuals.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Vonoprazan

CAS No.: 1260141-27-2

Pharmacy Grade

$3483/KG FOB

Magnesium oxide

CAS No.: 1309-48-4

Industrial Grade

$491-498/MT FOB

Famotidine (Gastrointestinal)

CAS No.: 76824-35-6

Pharmacy Grade

$1/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.